Filana Therapeutics (SAVA) Q3 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q3 2024
-0.88
-0.54
-0.21
0.13

Details

Expected EPS
-0.88
Actual EPS
-0.58
Surprise EPS
0.3
Surprise Percent
+34.09%

Description

Filana Therapeutics (SAVA) has reported earnings of -0.58 per share for Q3 2024.

0 Comments

Share your thoughts